Nevirapine-associated toxicity
Imperiale, M.
Aids Reader 12(4): 171
2002
ISSN/ISBN: 1053-0894 PMID: 12071188 Document Number: 542975
Document emailed within 1 workday
Related Documents
Bottaro, E.G.; Huberman, M.J.; Iannella, M.ía.D.C.; Vesperoni, F.A.án.; Scapellato, P.G.; Errea, S.; Antonelli, L.; Cassetti, L.I. 2010: Nevirapine-associated toxicity in clinical practice in Buenos Aires, Argentina Journal of the International Association of Physicians in Aids Care 9(5): 306-312Flys, T.S.; McConnell, M.S.; Matovu, F.; Church, J.D.; Bagenda, D.; Khaki, L.; Bakaki, P.; Thigpen, M.C.; Eure, C.; Fowler, M.Glenn.; Eshleman, S.H. 2008: Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission Journal of Infectious Diseases 198(4): 465-469
Jørgensen, L.B.; Katzenstein, T.L.; Gerstoft, J.; Mathiesen, L.R.; Pedersen, C.; Nielsen, C. 2000: Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine Antiviral Therapy 5(3): 187-194
Manosuthi, W.; Kiertiburanakul, S.; Chaovavanich, A.; Sungkanuparph, S. 2007: Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients Journal of the Medical Association of Thailand 90(2): 244-250
Romero, A.; Grau, M.T.; Villamayor, F.; Sacristán, A.; Ortiz, J.A. 1997: Toxicity of ebrotidine on reproduction. Toxicity on fertility and general reproductive performance, embryo-fetal toxicity and peri- and postnatal toxicity Arzneimittel-Forschung 47(4a): 504-510
Zijenah, L.S.; Kadzirange, G.; Rusakaniko, S.; Kufa, T.; Gonah, N.; Tobaiwa, O.; Gwanzura, C.; Matsikire, E.; Katzenstein, D.A. 2006: A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe Central African Journal of Medicine 52(1-2): 1-8
Morrow, D.H. 1970: Anesthesia and digitalis toxicity. VI. Effect of barbiturates and halothane on digoxin toxicity Anesthesia and Analgesia 49(2): 305-309
Kanisawa, M.; Suzuki, S.; Kozuka, Y.; Yamazaki, M. 1977: Histopathological studies on the toxicity of ochratoxin A in rats. I. Acute oral toxicity Toxicology and Applied Pharmacology 42(1): 55-64
Ono, A. 2010: Perspective of predictive toxicity assessment of in vivo repeated dose toxicity using structural activity relationship Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku 128: 44-49
Xu, L.; Zhang, Q.-l.; Gao, F.-p.; Nie, J.-s.; Niu, Q. 2010: Cell toxicity assessment methodologies applied in the study of the toxicity of nano-alumina to nerve cells Zhonghua Yu Fang Yi Xue Za Zhi 44(9): 785-789
Matsuzaki, M.; Sekino, M.; Fukushima, M.; Yoshida, A.; Asano, M. 1976: Studies on the toxicity of fusaric acid-Ca. II. Chronic toxicity in rats Japanese Journal of Antibiotics 29(5): 478-490
1996: FDA approval of nevirapine for HIV American Family Physician 54(5): 1805-1806
Koeda, T.; Odaki, M.; Hisamatsu, T.; Sasaki, H.; Yokota, M. 1973: Toxicity of 3',4'-dideoxykanamycin B. 2. Subacute toxicity in rats and rabbits Japanese Journal of Antibiotics 26(3): 228-246
Koeda, T.; Odaki, M.; Hisamatsu, T.; Sasaki, H.; Yokota, M. 1973: Toxicity of 3',4'-dideoxykanamycin B. 3. Chronic toxicity in rats and dogs Japanese Journal of Antibiotics 26(3): 247-261
Flaherty, B.; Krenzelok, E.P. 1997: Neonatal lithium toxicity as a result of maternal toxicity Veterinary and Human Toxicology 39(2): 92-93
Tauchi, K.; Kawanishi, H.; Igarashi, N.; Maeda, Y.; Maeyama, Y.; Ebino, K.; Suzuki, K.; Imamichi, T. 1979: Studies on the toxicity of cefadroxil (S-578). II. Subacute toxicity in rats Japanese Journal of Antibiotics 32(12): 1233-1257
Brooks, P.M.; Day, R.O. 1995: Toxicity of antirheumatic drugs. Toxicity Workgroup Leaders Journal of Rheumatology 22(5): 998-999
Phadke, M.A.; Bulakh, P.M.; Kshirsagar, N.A. 2008: Nevirapine to prevent HIV transmission via breastfeeding Lancet 372(9635): 287
Shegokar, R.; Singh, K.K. 2011: Nevirapine nanosuspensions for HIV reservoir targeting Die Pharmazie 66(6): 408-415
Black, V.; Rees, H. 2008: Incidence of nevirapine-associated hepatitis in an antenatal clinic South African Medical Journal 98(2): 116-118